市場調査レポート
商品コード
1176960

空間ゲノム・トランスクリプトミクスの世界市場:技術別 (空間トランスクリプトミクス、空間ゲノム)・製品別 (装置、消耗品、ソフトウェア)・用途別 (トランスレーショナルリサーチ、創薬)・エンドユーザー別の将来予測 (2027年まで)

Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 232 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
空間ゲノム・トランスクリプトミクスの世界市場:技術別 (空間トランスクリプトミクス、空間ゲノム)・製品別 (装置、消耗品、ソフトウェア)・用途別 (トランスレーショナルリサーチ、創薬)・エンドユーザー別の将来予測 (2027年まで)
出版日: 2022年12月20日
発行: MarketsandMarkets
ページ情報: 英文 232 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の空間ゲノム・トランスクリプトミクスの市場規模は、2022年の3億5,500万米ドルから、2027年には8億米ドルに達し、予測期間中に17.6%のCAGRで成長すると予測されています。

市場成長の主な要因として、神経変性疾患やがんなどの分野での、厳密な研究用途から創薬・開発への移行などが挙げられます。空間ゲノム・トランスクリプトミクスはまた、反応予測バイオマーカーの需要など、腫瘍学において現在満たされていない臨床ニーズに対応すると予想されます。

用途別では、トランスレーショナルリサーチ (TR) が2021年に最大のシェアを占めています。政府機関や非政府機関による研究助成金や資金提供の増加が、市場成長の一因となっています。

地域別に見ると、アジア太平洋が予測期間中に最も成長率の高い地域となっています。一方、北米諸国が最大の市場シェアを占めています。

当レポートでは、世界の空間ゲノム・トランスクリプトミクスの市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、技術別・製品別・用途別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術分析
    • 多重化
    • イメージングベースの技術進歩
    • データ解析
  • 顧客のビジネスに影響を与える動向/混乱
  • サプライチェーン分析
  • バリューチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制分析
  • 価格分析
  • パイプライン分析
  • 主な会議とイベント (2022年~2023年)
  • 主な利害関係者と購入基準

第6章 空間ゲノム・トランスクリプトミクス市場:技術別

  • イントロダクション
  • 空間トランスクリプトミクス
    • 免疫組織化学
    • in situハイブリダイゼーション
    • シーケンシング
    • その他のシーケンス技術
    • 顕微鏡ベースRNAイメージング
    • その他の空間トランスクリプトミクス技術
  • 空間ゲノム解析
    • 蛍光in situハイブリダイゼーション
    • シーケンシング
    • その他の空間ゲノム解析技術

第7章 空間ゲノム・トランスクリプトミクス市場:製品別

  • イントロダクション
  • 消耗品
  • 装置
  • ソフトウェア

第8章 空間ゲノム・トランスクリプトミクス市場:用途別

  • イントロダクション
  • トランスレーショナルリサーチ
  • 創薬・開発

第9章 空間ゲノム・トランスクリプトミクス市場:エンドユーザー別

  • イントロダクション
  • 教育・研究機関
  • CRO (医薬品開発業務受託機関)
  • 製薬企業・バイオテクノロジー企業

第10章 空間ゲノム・トランスクリプトミクス市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • 他のラテンアメリカ諸国
  • 中東・アフリカ
    • 南アフリカ
    • 他の中東・アフリカ諸国

第11章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 収益シェア分析(上位6社)
  • 市場シェア分析(2021年)
  • 企業評価クアドラント
  • 企業評価クアドラント:新興企業/中小企業
  • 競合ベンチマーキング
  • 競合シナリオと動向
    • 資本取引
    • 製品の発売
    • その他の動向

第12章 企業プロファイル

  • 主要企業
    • NANOSTRING TECHNOLOGIES
    • 10X GENOMICS
    • ILLUMINA
    • BIO-RAD LABORATORIES
    • BIO-TECHNE
    • STANDARD BIOTOOLS
    • GENOMIC VISION SA
    • AKOYA BIOSCIENCES
    • DANAHER CORPORATION
    • NATERA
    • PERKINELMER
    • SEVEN BRIDGES GENOMICS
    • S2 GENOMICS
    • CANTATA BIO
    • VIZGEN CORP
  • その他の企業
    • BIOSPYDER TECHNOLOGIES
    • OPTICAL BIOSYSTEMS
    • MILTENYL BIOTEC
    • RARECYTE
    • ULTIVUE
    • LUNAPHORE TECHNOLOGIES
    • REBUS BIOSYSTEMS
    • RESOLVE BIOSCIENCES
    • SINGULAR GENOMICS
    • VERACYTE

第13章 付録

目次
Product Code: BT 7790

The global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the shift from strictly research applications to drug discovery & development for areas such as neurodegenerative diseases and cancer. Spatial genomics and transcriptomics are also anticipated to address current unmet clinical needs in oncology, including the demand for predictive biomarkers of response. These biomarkers assist in developing immunotherapies by offering a greater understanding of the tumor. On the other hand, lack of clarity around outcomes of transcriptomic research, coupled with the high equipment cost, has led to the lower adoption of transcriptomic technologies, thereby limiting the growth of the spatial genomics & transcriptomics market.

"By application, the translational research accounted for the largest share of the spatial genomics & transcriptomics market"

Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.

"Asia Pacific: The fastest-growing region in the spatial genomics & transcriptomics market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing R&D spending in Asian countries is one of the major factors driving growth. In addition, Asian economies have modified regulations, policies, and guidelines to promote innovation and commercialization, attracting many domestic industrialists and global market leaders to establish their businesses in this region.

"North America: the largest share of the spatial genomics & transcriptomics market"

North America accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding for the development of new regenerative medicine, and technological advancements and launch of cell therapies to treat different cancers are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
  • By Region: North America -51%, Europe -25%, Asia-Pacific -18%, Latin America -3%, Middle East and Africa - 3%

Major Players

  • NanoString Technologies, Inc. (US)
  • 10X Genomics (US)
  • Illumina (US)
  • Bio-Rad Laboratories (US)
  • Bio-Techne Corporation (US)
  • Standard BioTools Inc. (US)
  • Genomic Vision SA (France)
  • Akoya Biosciences, Inc. (US)
  • Danaher Corporation (US)
  • Natera, Inc. (US)
  • PerkinElmer, Inc. (US)
  • Seven Bridges Genomics (US)
  • S2 Genomics, Inc. (US)
  • Cantata Bio (US)
  • Vizgen Corporation (US)
  • BioSpyder Technologies Inc. (US)
  • Optical Biosystems Inc. (US)
  • Miltenyi Biotec (Germany)
  • Ultivue Inc. (US)
  • Lunaphore Technologies SA (Switzerland)
  • Rebus Biosystems LLC (US)
  • Resolve Biosciences (Germany)
  • Singular Genomics, Inc. (US)
  • Veracyte (US)

Research Coverage:

This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2021 (USD MILLION)
    • FIGURE 5 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022-2027)
    • FIGURE 6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET DATA ESTIMATION & TRIANGULATION
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 INDUSTRY INSIGHTS
  • 2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
    • FIGURE 9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2021 VS. 2027 (USD MILLION)
    • FIGURE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION, 2021 VS. 2027
    • FIGURE 11 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW
    • FIGURE 13 INCREASING ADOPTION OF SPATIAL GENOMICS & TRANSCRIPTOMICS ANALYSIS IN TRANSLATIONAL RESEARCH TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT & COUNTRY (2021)
    • FIGURE 14 CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN 2021
  • 4.3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY END USER (2021)
    • FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery & development
      • 5.2.1.2 Introduction of novel products
      • 5.2.1.3 Increasing R&D investments and public-private funding
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital investments
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing use of spatial omics for biomarker identification
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals
  • 5.3 TECHNOLOGY ANALYSIS
    • 5.3.1 MULTIPLEXING
    • 5.3.2 IMAGING-BASED TECHNOLOGICAL ADVANCEMENTS
    • 5.3.3 DATA ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 19 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 20 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 DEGREE OF COMPETITION
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 FDA APPROVALS
    • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PRICING ANALYSIS
    • TABLE 7 PRICING ANALYSIS OF SPATIAL GENOMICS AND TRANSCRIPTOMICS PRODUCTS
    • 5.10.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: AVERAGE SELLING PRICE TREND
  • 5.11 PIPELINE ANALYSIS
  • 5.12 KEY CONFERENCES & EVENTS IN 2022-2023
    • 5.12.1 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023)
    • TABLE 8 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023)
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • 5.13.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS
    • FIGURE 22 KEY BUYING CRITERIA FOR END USERS

6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE

  • 6.1 INTRODUCTION
    • TABLE 9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  • 6.2 SPATIAL TRANSCRIPTOMICS
    • TABLE 10 SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 11 SPATIAL TRANSCRIPTOMICS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 12 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 13 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 15 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 16 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 IMMUNOHISTOCHEMISTRY
      • 6.2.1.1 Emergence of mIHC/IF to propel growth
    • TABLE 17 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 18 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 19 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 21 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 22 MIDDLE EAST & AFRICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 IN SITU HYBRIDIZATION
      • 6.2.2.1 High adoption of MERFISH to drive growth
    • TABLE 23 IN SITU HYBRIDIZATION MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 24 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 25 EUROPE: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 LATIN AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 28 MIDDLE EAST & AFRICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 SEQUENCING
    • TABLE 29 SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 30 NORTH AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 31 EUROPE: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 33 LATIN AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 34 MIDDLE EAST & AFRICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
      • 6.2.3.1 Microdissection-based sequencing
        • 6.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
      • 6.2.3.2 In situ sequencing
        • 6.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
    • 6.2.4 OTHER SEQUENCING TECHNOLOGIES
    • 6.2.5 MICROSCOPY-BASED RNA IMAGING
      • 6.2.5.1 Rising use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
    • TABLE 35 MICROSCOPY-BASED RNA IMAGING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 37 EUROPE: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 38 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 39 LATIN AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 40 MIDDLE EAST & AFRICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
  • 6.3 SPATIAL GENOMICS ANALYSIS
    • TABLE 41 SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 42 SPATIAL GENOMICS ANALYSIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 44 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 46 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 47 MIDDLE EAST & AFRICA: OTHER SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
      • 6.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support market growth
    • TABLE 48 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 49 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 50 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 52 LATIN AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 53 MIDDLE EAST & AFRICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.2 SEQUENCING
      • 6.3.2.1 Rising adoption of massively parallel sequencing to drive growth
    • TABLE 54 SEQUENCING TECHNIQUES MARKET FOR SPATIAL GENOMICS ANALYSIS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 55 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 58 LATIN AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 MIDDLE EAST & AFRICA: SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
    • TABLE 60 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 64 LATIN AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 65 MIDDLE EAST & AFRICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 66 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 7.2 CONSUMABLES
    • 7.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE MARKET GROWTH
    • TABLE 67 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 68 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 69 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 71 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 72 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 INSTRUMENTS
    • 7.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
    • TABLE 73 SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 75 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 77 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 78 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 SOFTWARE
    • 7.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
    • TABLE 79 SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 80 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 81 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 83 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 85 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 TRANSLATIONAL RESEARCH
    • 8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE SEGMENT GROWTH
    • TABLE 86 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 87 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 88 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 90 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 91 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 DRUG DISCOVERY & DEVELOPMENT
    • 8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE MARKET
    • TABLE 92 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 93 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 94 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 96 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 97 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)

9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 98 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 ACADEMIC & RESEARCH INSTITUTES
    • 9.2.1 INCREASED DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
    • TABLE 99 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 100 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 101 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 103 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 104 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS
    • 9.3.1 INCREASING DEPENDENCE ON CONTRACT RESEARCH TO DRIVE MARKET
    • TABLE 105 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 106 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 107 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 109 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 110 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS SYSTEMS
    • TABLE 111 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 112 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 113 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 115 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)

10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 23 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
    • TABLE 117 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
    • TABLE 118 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 119 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 120 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 123 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 124 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate North American market
    • TABLE 125 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 126 US: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 US: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 129 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 130 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives to contribute to market growth
    • TABLE 131 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 132 CANADA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 CANADA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 135 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 136 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 137 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 138 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 139 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 142 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 143 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing adoption of spatial genomics and transcriptomics by biopharma & biotech companies to drive market growth
    • TABLE 144 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 145 GERMANY: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 GERMANY: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 148 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 149 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising government support for biotech companies to propel demand for advanced technologies
    • TABLE 150 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 151 UK: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 UK: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 154 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 155 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing investments in life sciences R&D infrastructure development to support market growth
    • TABLE 156 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 157 FRANCE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 FRANCE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 160 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 161 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 REST OF EUROPE
    • TABLE 162 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 163 ROE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 ROE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 166 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 167 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 25 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
    • TABLE 168 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 173 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 174 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Increasing R&D spending by government and biopharma companies to support market growth
    • TABLE 175 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 176 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 179 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 180 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising funding in Japan to boost research applications
    • TABLE 181 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 182 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 183 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 185 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 186 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Collaborations between hospitals and diagnostics centers for laboratory services to boost growth
    • TABLE 187 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 188 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 191 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 192 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 193 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 194 ROAPAC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 195 ROAPAC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 197 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 198 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 199 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 200 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 201 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 204 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 205 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Increased adoption of spatial analysis for translational research in Brazil likely to propel market
    • TABLE 206 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 207 BRAZIL: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 BRAZIL: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 210 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 211 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Growing attention of investors on opportunities in Mexico to support growth
    • TABLE 212 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 213 MEXICO: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 MEXICO: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 215 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 216 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 217 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 218 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 219 ROLATAM: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 ROLATAM: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 222 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 223 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • TABLE 224 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 225 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 226 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 227 MIDDLE EAST & AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 228 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 229 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 230 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.1 SOUTH AFRICA
      • 10.6.1.1 Growing investments in R&D to support market development
    • TABLE 231 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 232 SOUTH AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 233 SOUTH AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 234 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 235 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 236 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.2 REST OF MIDDLE EAST & AFRICA
    • TABLE 237 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 238 ROMEA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 239 ROMEA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 240 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 241 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 242 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)
    • FIGURE 27 REVENUE ANALYSIS FOR TOP SIX COMPANIES, 2018-2021
  • 11.4 MARKET SHARE ANALYSIS (2021)
    • FIGURE 28 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: MARKET SHARE ANALYSIS OF TOP SIX PLAYERS (2021)
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 29 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT (2021)
  • 11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 30 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF START-UPS/SMES
    • TABLE 243 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF START-UPS/SMES
      • 11.7.1.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
    • TABLE 244 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
  • 11.8 COMPETITIVE SCENARIO AND TRENDS
    • 11.8.1 DEALS
    • TABLE 245 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS
    • 11.8.2 PRODUCT LAUNCHES
    • TABLE 246 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
    • 11.8.3 OTHER DEVELOPMENTS
    • TABLE 247 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 NANOSTRING TECHNOLOGIES
    • TABLE 248 NANOSTRING TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 31 NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT (2021)
    • 12.1.2 10X GENOMICS
    • TABLE 249 10X GENOMICS: BUSINESS OVERVIEW
    • FIGURE 32 10X GENOMICS: COMPANY SNAPSHOT (2021)
    • 12.1.3 ILLUMINA
    • TABLE 250 ILLUMINA: BUSINESS OVERVIEW
    • FIGURE 33 ILLUMINA: COMPANY SNAPSHOT (2021)
    • 12.1.4 BIO-RAD LABORATORIES
    • TABLE 251 BIO-RAD: BUSINESS OVERVIEW
    • FIGURE 34 BIO-RAD: COMPANY SNAPSHOT (2021)
    • 12.1.5 BIO-TECHNE
    • TABLE 252 BIO-TECHNE: BUSINESS OVERVIEW
    • FIGURE 35 BIO-TECHNE: COMPANY SNAPSHOT (2021)
    • 12.1.6 STANDARD BIOTOOLS
    • TABLE 253 STANDARD BIOTOOLS: BUSINESS OVERVIEW
    • FIGURE 36 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
    • 12.1.7 GENOMIC VISION SA
    • TABLE 254 GENOMIC VISION: BUSINESS OVERVIEW
    • FIGURE 37 GENOMIC VISION: COMPANY SNAPSHOT (2021)
    • 12.1.8 AKOYA BIOSCIENCES
    • TABLE 255 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
    • FIGURE 38 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
    • 12.1.9 DANAHER CORPORATION
    • TABLE 256 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.10 NATERA
    • TABLE 257 NATERA: BUSINESS OVERVIEW
    • FIGURE 40 NATERA: COMPANY SNAPSHOT (2021)
    • 12.1.11 PERKINELMER
    • TABLE 258 PERKINELMER: BUSINESS OVERVIEW
    • FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2021)
    • 12.1.12 SEVEN BRIDGES GENOMICS
    • TABLE 259 SEVEN BRIDGES GENOMICS: BUSINESS OVERVIEW
    • 12.1.13 S2 GENOMICS
    • TABLE 260 S2 GENOMICS: BUSINESS OVERVIEW
    • 12.1.14 CANTATA BIO
    • TABLE 261 CANTATA BIO: BUSINESS OVERVIEW
    • 12.1.15 VIZGEN CORP
    • TABLE 262 VIZGEN: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 BIOSPYDER TECHNOLOGIES
    • 12.2.2 OPTICAL BIOSYSTEMS
    • 12.2.3 MILTENYL BIOTEC
    • 12.2.4 RARECYTE
    • 12.2.5 ULTIVUE
    • 12.2.6 LUNAPHORE TECHNOLOGIES
    • 12.2.7 REBUS BIOSYSTEMS
    • 12.2.8 RESOLVE BIOSCIENCES
    • 12.2.9 SINGULAR GENOMICS
    • 12.2.10 VERACYTE
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS